Report for Huang XP

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (15)

Title : An esterase-responsive ibuprofen nano-micelle pre-modified embryo derived nucleus pulposus progenitor cells promote the regeneration of intervertebral disc degeneration - Xia_2023_Bioact.Mater_21_69
Author(s) : Xia KS , Li DD , Wang CG , Ying LW , Wang JK , Yang B , Shu JW , Huang XP , Zhang YA , Yu C , Zhou XP , Li FC , Slater NKH , Tang JB , Chen QX , Liang CZ
Ref : Bioact Mater , 21 :69 , 2023
Abstract : Xia_2023_Bioact.Mater_21_69
ESTHER : Xia_2023_Bioact.Mater_21_69
PubMedSearch : Xia_2023_Bioact.Mater_21_69
PubMedID: 36017070

Title : NMDAR inhibition-independent antidepressant actions of ketamine metabolites - Zanos_2016_Nature_533_481
Author(s) : Zanos P , Moaddel R , Morris PJ , Georgiou P , Fischell J , Elmer GI , Alkondon M , Yuan P , Pribut HJ , Singh NS , Dossou KS , Fang Y , Huang XP , Mayo CL , Wainer IW , Albuquerque EX , Thompson SM , Thomas CJ , Zarate CA, Jr. , Gould TD
Ref : Nature , 533 :481 , 2016
Abstract : Zanos_2016_Nature_533_481
ESTHER : Zanos_2016_Nature_533_481
PubMedSearch : Zanos_2016_Nature_533_481
PubMedID: 27144355

Title : Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor - Shivnaraine_2012_Biochemistry_51_4518
Author(s) : Shivnaraine RV , Huang XP , Seidenberg M , Ellis J , Wells JW
Ref : Biochemistry , 51 :4518 , 2012
Abstract : Shivnaraine_2012_Biochemistry_51_4518
ESTHER : Shivnaraine_2012_Biochemistry_51_4518
PubMedSearch : Shivnaraine_2012_Biochemistry_51_4518
PubMedID: 22551249

Title : Automated design of ligands to polypharmacological profiles - Besnard_2012_Nature_492_215
Author(s) : Besnard J , Ruda GF , Setola V , Abecassis K , Rodriguiz RM , Huang XP , Norval S , Sassano MF , Shin AI , Webster LA , Simeons FR , Stojanovski L , Prat A , Seidah NG , Constam DB , Bickerton GR , Read KD , Wetsel WC , Gilbert IH , Roth BL , Hopkins AL
Ref : Nature , 492 :215 , 2012
Abstract : Besnard_2012_Nature_492_215
ESTHER : Besnard_2012_Nature_492_215
PubMedSearch : Besnard_2012_Nature_492_215
PubMedID: 23235874

Title : Design, synthesis, and biological characterization of bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective muscarinic agonists - Rajeswaran_2001_J.Med.Chem_44_4563
Author(s) : Rajeswaran WG , Cao Y , Huang XP , Wroblewski ME , Colclough T , Lee S , Liu F , Nagy PI , Ellis J , Levine BA , Nocka KH , Messer WS, Jr.
Ref : Journal of Medicinal Chemistry , 44 :4563 , 2001
Abstract : Rajeswaran_2001_J.Med.Chem_44_4563
ESTHER : Rajeswaran_2001_J.Med.Chem_44_4563
PubMedSearch : Rajeswaran_2001_J.Med.Chem_44_4563
PubMedID: 11741475

Title : Poster: Synthesis and biological evaluation of bivalent xanomeline analogs as M1 muscarinic agonists -
Author(s) : Messer WS, Jr. , Rajeswaran WG , Cao Y , Huang XP , Wroblewski ME , Nagy PI
Ref : Life Sciences , 68 :2625 , 2001
PubMedID:

Title : Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors - Messer_2000_Pharm.Acta.Helv_74_135
Author(s) : Messer WS, Jr. , Rajeswaran WG , Cao Y , Zhang HJ , el-Assadi AA , Dockery C , Liske J , O'Brien J , Williams FE , Huang XP , Wroblewski ME , Nagy PI , Peseckis SM
Ref : Pharm Acta Helv , 74 :135 , 2000
Abstract : Messer_2000_Pharm.Acta.Helv_74_135
ESTHER : Messer_2000_Pharm.Acta.Helv_74_135
PubMedSearch : Messer_2000_Pharm.Acta.Helv_74_135
PubMedID: 10812950

Title : Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors - Huang_1999_Br.J.Pharmacol_126_735
Author(s) : Huang XP , Nagy PI , Williams FE , Peseckis SM , Messer WS, Jr.
Ref : British Journal of Pharmacology , 126 :735 , 1999
Abstract : Huang_1999_Br.J.Pharmacol_126_735
ESTHER : Huang_1999_Br.J.Pharmacol_126_735
PubMedSearch : Huang_1999_Br.J.Pharmacol_126_735
PubMedID: 10188986

Title : Differential modulation of agonist potency and receptor coupling by mutations of Ser388Tyr and Thr389Pro at the junction of transmembrane domain VI and the third extracellular loop of human M(1) muscarinic acetylcholine receptors - Huang_1999_Mol.Pharmacol_56_775
Author(s) : Huang XP , Williams FE , Peseckis SM , Messer WS, Jr.
Ref : Molecular Pharmacology , 56 :775 , 1999
Abstract : Huang_1999_Mol.Pharmacol_56_775
ESTHER : Huang_1999_Mol.Pharmacol_56_775
PubMedSearch : Huang_1999_Mol.Pharmacol_56_775
PubMedID: 10496961

Title : Poster: Activity of selective muscarinic agonists at human M1 receptors expressed at varying levels in A9 L cells -
Author(s) : Cao Y , Wise DD , Zhang H , Huang XP , Messer WS, Jr.
Ref : Life Sciences , 64 :571 , 1999
PubMedID:

Title : Poster: Mutant M1 muscarinic receptors with increased agonist affinity and G protein coupling -
Author(s) : Messer WS, Jr. , Huang XP , Nagy PI , Williams FE , Peseckis SM
Ref : Life Sciences , 64 :563 , 1999
PubMedID:

Title : Poster: Mutant M1 muscarinic receptors with enhanced agonist activity -
Author(s) : Huang XP , Williams FE , Peseckis SM , Messer WS, Jr.
Ref : Life Sciences , 64 :563 , 1999
PubMedID:

Title : Pharmacological characterization of human m1 muscarinic acetylcholine receptors with double mutations at the junction of TM VI and the third extracellular domain - Huang_1998_J.Pharmacol.Exp.Ther_286_1129
Author(s) : Huang XP , Williams FE , Peseckis SM , Messer WS, Jr.
Ref : Journal of Pharmacology & Experimental Therapeutics , 286 :1129 , 1998
Abstract : Huang_1998_J.Pharmacol.Exp.Ther_286_1129
ESTHER : Huang_1998_J.Pharmacol.Exp.Ther_286_1129
PubMedSearch : Huang_1998_J.Pharmacol.Exp.Ther_286_1129
PubMedID: 9732369

Title : Poster: Molecular studies of agonist interactions with wild-type, T234A, and N507A m3 receptors -
Author(s) : Huang XP , Edgar MA , Freed J , Peseckis SM , Nagy PI , Ojo B , Zhang H , Messer WS, Jr.
Ref : Life Sciences , 60 :1178 , 1997
PubMedID:

Title : Poster: Development of 5-(3-alkenyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine derivatives as selective muscarinic agonists for the treatment of Alzheimer's disease -
Author(s) : Zhang H , Ojo B , Huang XP , Edgar MA , el-Assadi AA , Baril D , Lynch K , Wahidy S , Nagy PI , Messer WS, Jr.
Ref : Life Sciences , 60 :1163 , 1997
PubMedID: